Skip to content

Source filing unavailable

Q1 2019 · —
Revenue—
Net Income-$10.77Mno prior Q1 2018 on file
EPS, diluted—
Operating Incomederived-$7,813—
Operating Cash Flowderived-$9,813—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q1 2018 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Compass Therapeutics, Inc. · CIK 1738021 · Engraved from SEC EDGAR